January 2026 Research Update

This month, the main new message about metachromatic leukodystrophy (MLD) was that adult-onset MLD can closely resemble multiple system atrophy (MSA), a different brain disorder that can cause movement and autonomic problems. In one report of two first cousins thought to have MSA, genetic testing showed that one person actually had late-onset MLD, while the other did not share the same genetic cause. This highlights how the same outward symptoms can come from different underlying conditions, and that genetics can sometimes clarify what is really going on. [1]

In that family, one cousin had two ARSA gene changes (biallelic ARSA mutations), which is consistent with late-onset MLD and led to a diagnosis change from MSA to MLD. The other cousin did not have shared disease-causing genetic variants in the testing reported, meaning the pair did not fit a simple story of a single inherited cause for both people. For patients, the practical takeaway is not that MLD is common in MSA, but that it is one of the rare conditions that can imitate it, especially when there is concern about a familial pattern. [1]

For patients and caregivers, this mainly adds understanding about diagnosis rather than treatment. It shows that in some adults with MSA-like symptoms (movement changes plus problems like low blood pressure on standing or bladder issues), late-onset MLD may be part of the diagnosis discussion if genetic results support it, and genetic testing can sometimes overturn an earlier label. What remains uncertain is how often this happens, because this evidence comes from only two related individuals and only one had MLD confirmed by genetics. [1]

This month also included a rare single-patient report suggesting that MLD may sometimes be seen alongside unexpected problems outside the nervous system. In a 5-year-old boy with genetically confirmed MLD, doctors found a gallbladder mucinous adenocarcinoma (a type of gallbladder cancer) along with signs of MLD-related brain changes and neurological decline. Because this is a one-person report, it does not show that MLD causes gallbladder cancer, but it documents that this combination can occur. [2]

The case connected the MLD diagnosis to low ARSA enzyme activity and evidence of sulfatide buildup (the fatty substance that accumulates in MLD), including staining that showed metachromatic material in gallbladder tissue. The tumor also had a low-frequency somatic KMT2C mutation, which the authors discussed as a possible contributor to the cancer in that specific tumor. For families, this adds a concrete example that MLD is a whole-body condition at the biochemical level, even though most attention is on the brain and nerves. [2]

For patients and caregivers, this information mainly matters as early research and documentation, not as a change to routine care. It expands the picture of what has been observed in MLD by describing a very unusual gallbladder finding in a young child with confirmed MLD and clear brain imaging changes. What remains uncertain is whether this was coincidence or part of a broader pattern, because there is only one reported pediatric case and follow-up was limited. [2]